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Abstract
Background: Designing sustainable animal production systems that better balance productivity and resistance to 
disease is a major concern. In order to address questions related to immunity and resistance to disease in pig, it is 
necessary to increase knowledge on its immune system and to produce efficient tools dedicated to this species.
Results: A long-oligonucleotide-based chip referred to as SLA-RI/NRSP8-13K was produced by combining a generic 
set with a newly designed SLA-RI set that targets all annotated loci of the pig major histocompatibility complex (MHC) 
region (SLA complex) in both orientations as well as immunity genes outside the SLA complex.
The chip was used to study the immune response of pigs following stimulation of porcine peripheral blood
mononuclear cells (PBMCs) with lipopolysaccharide (LPS) or a mixture of phorbol myristate acetate (PMA) and
ionomycin for 24 hours. Transcriptome analysis revealed that ten times more genes were differentially expressed after
PMA/ionomycin stimulation than after LPS stimulation. LPS stimulation induced a general inflammation response with
over-expression of SAA1, pro-inflammatory chemokines IL8, CCL2, CXCL5, CXCL3, CXCL2 and CCL8 as well as genes
related to oxidative processes (SOD2) and calcium pathways (S100A9 and S100A12). PMA/ionomycin stimulation
induced a stronger up-regulation of T cell activation than of B cell activation with dominance toward a Th1 response,
including IL2, CD69 and TNFRSF9 (tumor necrosis factor receptor superfamily, member 9) genes. In addition, a very
intense repression of THBS1 (thrombospondin 1) was observed. Repression of MHC class I genes was observed after
PMA/ionomycin stimulation despite an up-regulation of the gene cascade involved in peptide processing. Repression
of MHC class II genes was observed after both stimulations. Our results provide preliminary data suggesting that
antisense transcripts mapping to the SLA complex may have a role during immune response.
Conclusion: The SLA-RI/NRSP8-13K chip was found to accurately decipher two distinct immune response activations 
of PBMCs indicating that it constitutes a valuable tool to further study immunity and resistance to disease in pig. The 
transcriptome analysis revealed specific and common features of the immune responses depending on the 
stimulation agent that increase knowledge on pig immunity.
Background
Understanding resistance to disease is a major concern
for all living organisms. Thus, it is necessary to design
strategies to address related questions according to scien-
tific and economic contexts. In farm animals like pig,
zootechnical performances including growth, meat qual-
ity, feed intake or prolificacy have increased considerably
during the last 25 years as a result of both the application
of rational genetic selection schemes [1], and the
improvement of feed formulations and sanitary condi-
tions in breeding units. However at the same time, dis-
eases have emerged that can cause substantial economic
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loss. Intensive research is carried out to better under-
stand the etiology of emerging as well as endemic dis-
eases in pig and raises questions on host pathogen
interactions, pathogen latency, pathogen shedding, vac-
cine efficiency and host immune response. Thus, produc-
ing efficient methods and tools for these studies and
improving basic knowledge on immune response in pig
are major issues.
With the explosion of information on genome
sequences and the emergence of functional genomics, it
is now possible to study the expression of many genes in a
single experiment. The development of DNA chips for
genome-wide expression studies [2] and the next genera-
tion sequencing (NGS) technology for much deeper tran-
scriptome analyses [3] are complementary approaches to
conduct functional genomics research [4]. DNA chip-
based transcriptome analyses are efficient to study host-
pathogen interactions using either pathogen transcrip-
tomes [5] or host transcriptomes [6-9] or both pathogen
and host modifications of the transcriptome during infec-
tion [10]. Thus, DNA chips are still highly valuable to
analyze large numbers of samples and in the case of
domestic animals, it is essential to develop well-anno-
tated DNA chips and sequence-based transcriptome
using the NGS technology.
One major concern in designing a DNA chip-based
experiment is to use the most appropriate and relevant
array. For human and laboratory animals like mouse, the
genomes are almost fully annotated, thus chips represent-
ing all the annotated genes are commercially available. In
pig, the genome sequence is in progress and a first assem-
bly has been released [11]. Today, many commercial and
custom-made genome-wide microarrays exist for pig but
probe annotation of these arrays is still poor because of
the limited availability of full length cDNA sequences in
pig [12]. Available porcine DNA chips include a 9 K
cDNA-based microarray on nylon membranes [13], a
1789 DNA/cDNA microarray including a subset of
probes specific for the SLA locus, a subset of immune
response genes outside the SLA complex, and a subset of
randomly chosen probes [10], the ARK-Genomics Sus
scrofa Immune Array 3 K v1.0 [14], the Sus scrofa AROS
(Array-Ready Oligo Sets) V1.1 (Operon Biotechnologies
Inc., USA), the GeneChip®  Porcine Genome Array
(Affymetrix, USA), a 25 K porcine long-oligonuclotide
DNA microarray [15], and the Swine Protein-Annotated
Oligonucleotide Microarray [16]. The immune system
represents a complex network involving many regulation
points and the genome-wide generic arrays that have
been developed in pig only partially cover the genome
and lack many immune response genes. As an example,
the Major Histocompatibility Complex (MHC), which
plays a key role in innate, adaptive immune response as
well as in inflammation in mammals, is only poorly repre-
sented on existing pig expression arrays.
The objectives of our study were first to produce a
generic array enriched in MHC and immunity-related
genes and second to study transcriptome modifications
of porcine peripheral blood mononuclear cells (PBMCs)
after in vitro stimulation of the immune response. We
describe the SLA-RI/NRSP8-13K chip that combines the
generic Qiagen-NRSP8-13K set [17] with a long-oligonu-
cleotide set comprising all the genes and pseudogenes
annotated for the pig MHC referred to as the SLA (Swine
Leucocyte Antigen) complex as well as immune response
genes outside the SLA complex. We report the use of this
array to investigate the differential expression of genes in
PBMCs stimulated with lipopolysaccharide (LPS) or a
mixture of Phorbol Myristate Acetate (PMA) and iono-
mycin for 24 hours. LPS is part of the outermost layer of
gram-negative bacteria and is a pathogen-associated
molecular pattern (PAMP) used for in vitro studies of the
innate immune response after bacterial infection. PMA, a
phorbol diester, is a potent tumor promoter often used in
biomedical research to activate the signal transduction
enzyme protein kinase C and a potent mitogen for
PBMCs. Ionomycin is a ionophore that stimulates the
intracellular production of the cytokines IL-2 and IL-4 in
conjunction with PMA. Both these stimulations with
either LPS or PMA/ionomycin were chosen because they
are widely used to stimulate immune response in vitro.
Our results show that some biological pathways and gene
networks are differentially expressed in PBMCs accord-
ing to stimulation. They provide new data on pig immu-
nity and validate the relevance of the SLA-RI/NRSP8-13K
chip for further studies on immunity and immune
response to stimuli and pathogens in pig.
Results
Design of the porcine SLA-RI/NRSP8-13K chip
The porcine chip referred to as SLA-RI/NRSP8-13K chip
includes a newly designed SLA-RI oligonucleotide set,
the Qiagen-NRSP8 microarray oligonucleotide set [17]
and a series of positive and negative control elements
(Table 1). To prepare the SLA oligonucleotide subset, we
selected the 151 genes and pseudogenes annotated in the
SLA complex. This set comprises 816 probes: 410 probes
in sense orientation and 406 probes in anti-sense orienta-
tion. The RI subset comprises 2957 probes of which 2832
are designed from pig sequences and 125 from human
sequences. The detailed information on probes and on
gene ontology (GO) is summarized in the Additional files
1 (SLA_RI_Table_S1.xls) and 2 (SLA_RI_Table_S2.doc),
respectively. The SLA-RI set was uploaded into the ani-
mal QTL database [18] in order to visualize probes on
existing porcine maps. Therefore, the position of probesGao et al. BMC Genomics 2010, 11:292
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from both SLA-RI and NRSP8-13K sets can be visualized
via the QTLdb web viewer.
Differentially expressed genes in PBMCs stimulated with 
LPS or PMA/ionomycin
Transcriptome analyses were carried out using a dye-
swap hybridization scheme to compare gene expressions
between mock-stimulated PBMCs and PBMCs stimu-
lated with either LPS or a mixture of PMA and ionomycin
during 24 hours. Comparison of LPS stimulated and
mock-stimulated PBMCs, revealed 403 differentially
expressed probes (Figure 1 and Table 2) among which 162
originated from the SLA-RI set (40.2%) and 241 from the
NRSP8-13K set (59.8%). Up-regulation was observed for
263 probes (65.3%) and down-regulation for 140 probes
(34.7%). Comparison of PMA/ionomycin stimulated and
mock-stimulated PBMCs, revealed 4029 differentially
expressed probes (Figure 1 and Table 2) among which 869
originated from the SLA-RI set (21.6%) and 3160 from
the NRSP8-13K set (78.4%). Up-regulation was observed
for 2376 probes (59%) and down-regulation for 1653
probes (41%). Thus about ten times more genes are dif-
ferentially expressed in PMA/ionomycin stimulated
PBMCs than in LPS stimulated PBMCs. With both stimu-
lation agents, more genes were up-regulated than down-
regulated. We observed six GO annotations specific to
PMA/ionomycin stimulation but only one specific to LPS
stimulation (Figure 1). Comparison of the top-ten differ-
entially expressed genes between the two stimulations
applied (Table 3), found no common up-regulated gene,
but five common down-regulated genes namely lysozyme
Table 2: Number of probes differentially expressed by PBMCs stimulated with LPS or PMA/ionomycin
Probe set Regulation LPS PMA/ionomycin
SLA-RI Up 98 377
Down 64 492
Sub-total 162 869
NRSP8-13K Up 165 1999
Down 76 1161
Sub-total 241 3160
Total 403 4029
Table 1: Construction of SLA-RI/NRSP8-13K chip
Sets Probes Number of probes Number of genes
SLA-RI
SLA subset
gene or pseudogenes 804
non-coding RNA 12
RI subset
Porcine sequence 2832
Human sequence 125
Sub-total 3773 3104
NRSP8-13K 13297 8541
Control sets Lucidea Universal ScoreCard 92
SpotReport Alien Control 40
Position or Negative Control 1998
Total 19200 100101
1 The total gene number is 10010 because 1635 genes are found in both gene setsGao et al. BMC Genomics 2010, 11:292
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(LYZ), fibronectin 1 (FN1), folate receptor 1 (FOLR1),
cystatin C (CST3) and cystatin SA (CST2).
Cluster analysis of common differentially expressed genes 
in PBMCs stimulated with LPS or PMA/ionomycin
LPS and PMA/ionomycin stimulated PBMCs shared 316
differentially expressed probes (Figure 1) of which 244
were regulated in the same direction (124 up-regulated
and 120 down-regulated), 65 up-regulated after LPS stim-
ulation and down-regulated after PMA/ionomycin stimu-
lation and seven down-regulated after LPS stimulation
and up-regulated after PMA/ionomycin stimulation
(Additional file 3: SLA_RI_Table_S3.doc). Hierarchical
clustering classified these 316 probes into eight clusters
C1 to C8 (Figure 2, and Additional file 4:
SLA_RI_Figure_S4.png) and four cluster types. Clusters
C1 and C8 contain probes down-regulated after either
stimulation. Cluster C1 comprises six probes represent-
ing the three genes FN1, FOLR1 and LYZ, which are part
of the top-ten most down-regulated genes (Table 3).
Cluster C8 consists of 116 probes targeting at least 80
genes, which are involved in the following biological pro-
cesses: immune system process, response to stimulus,
biological adhesion and biological regulation. C8 includes
MHC class II genes coding for light and heavy chains of
the DR (DRA, DRB) and DQ series (DQA, DQB), the non
classical MHC gene CD1, TGFB1, cystatin, cathepsin,
and toll-like receptor TLR6 and TLR8 genes. Clusters C3
and C6 contain up-regulated genes after either stimula-
tion. In cluster C3, up-regulation of genes was higher
after LPS stimulation. This cluster contains four probes
targeting the genes interleukin 8 (IL8 alias AMCF-I in
pig) and S100 calcium binding protein A9 (S100A9) that
belong to the top-ten most up-regulated genes after LPS
stimulation (Table 3). Cluster C6 consists of 118 probes
targeting at least 79 genes involved in the same biological
processes as for cluster C8 with two more i.e. viral repro-
duction and multi-organism process. C6 includes many
genes coding for heat shock proteins, CD44, chemokines,
and proteasome-associated genes (Figure 2). The three
clusters C2 (two probes for one gene), C4 (seven probes
for five genes) and C7 (56 probes for 40 genes at least)
group probes that were up-regulated after LPS stimula-
tion and down-regulated after PMA/ionomycin stimula-
tion whereas cluster C5 (seven probes for seven genes)
contains probes down-regulated after LPS stimulation
but up-regulated after PMA/ionomycin stimulation. The
genes encoding immunoglobulins (IgM, IgA, IgG4,
IgG2b, Igh-V) are found in cluster C7. Clusters C2 and C4
contain very few genes, mainly the most differentially
expressed genes (Table 3), i.e. THBS1, SAA1, CCL2,
CXCL5 and CXCL6.
Overview and comparison of affected biological functions 
in PBMCs during LPS or PMA/ionomycin stimulation
Three hundred and sixty-four genes from the 403 differ-
entially expressed probes after LPS stimulation were
mapped into the Ingenuity Pathway Analysis (IPA) sys-
tem and 248 network eligible genes and 236 function eli-
gible genes were found. Three thousand five hundred and
sixty-eight genes from the 4029 differentially expressed
probes found between mock-stimulated and PMA/iono-
mycin-stimulated PBMCs, were also mapped in the IPA
system, leading to the identification of 2476 network eli-
gible genes and 2115 function eligible genes. The num-
bers of molecules in each category of biological functions
related to the different catalogs are given in Figure 3 and
Table 4. In the catalog Diseases and Disorders, 21 and 14
biological function categories are covered respectively for
LPS and PMA/ionomycin stimulations. The number of
represented biological function categories after PMA/
ionomycin stimulation is considerably reduced in com-
parison to LPS stimulation despite four times more dif-
ferentially expressed genes. The two most represented
biological function categories are common to both stimu-
lations and concern first cancer and second immunologi-
cal diseases (Figure 3A). In the catalog Molecular and
Cellular Function, 14 and 17 biological function catego-
ries are covered respectively for LPS and PMA/ionomy-
cin stimulations. The two most represented biological
function categories are first cellular growth and prolifera-
Figure 1 Venn diagram representing the number of probes that 
were found differentially expressed after LPS or PMA/ionomycin 
stimulation compared to mock-stimulation. The number of probes 
identified from the SLA-RI subset is indicated within brackets. The 
number of genes sharing the same GO is indicated in squares connect-
ed to the different parts of the diagram by arrows. GO annotations that 
were found specific to LPS or PMA/ionomycin stimulation are indicat-
ed in italic letters.
87
(33)
316
(129)
3713
(740)
LPS stimulation vs. 
mock-stimulation 
403 (162) 
(~258 genes) 
PMA/ionomycin stimulation vs. 
mock-stimulation 
4029 (869) 
(~2689 genes) 
GO:0050896~response  to  stimulus     26 
GO:0032502~developmental  process    22 
GO:0032501~multicellular organismal process  22 
GO:0051704~multi-organism  process      5 
GO:0009987~cellular  process    1943 
GO:0008152~metabolic  process    1507 
GO:0065007~biological regulation      855 
GO:0010467~gene  expression      663 
GO:0032502~developmental process      532 
GO:0051179~localization       476 
GO:0050896~response to stimulus       470 
GO:0051234~establishment of localization    410 
GO:0002376~immune system process      236 
GO:0022610~biological  adhesion      125 
GO:0040007~growth          60 
GO:0051704~multi-organism  process      59 
GO:0001906~cell  killing           7 
GO:0009987~cellular process    162 
GO:0065007~biological regulation    84 
GO:0002376~immune system process    63 
GO:0051179~localization      47 
GO:0051704~multi-organism process    14 
GO:0022414~reproductive  process    9 
GO:0016032~viral  reproduction      6 Gao et al. BMC Genomics 2010, 11:292
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tion and second cell death. In the case of LPS stimulation,
some biological function categories are missing among
which cellular assembly and organization, cellular func-
tion and maintenance and functions related to DNA rep-
lication, RNA modification and protein expression
(Figure 3B). In the catalog Physiological System Develop-
ment and Function (Figure 3C), 11 and 9 biological func-
tion categories are covered respectively for LPS and
PMA/ionomycin stimulations. The three most repre-
sented functions are common to both stimulations and
include immune system, hematological system develop-
ment and function and immune and lymphatic system
development and function. The function referred to as
organismal survival is covered by a large set of 290 genes
differentially expressed after PMA/ionomycin stimula-
tion but is missing in the gene set differentially expressed
after LPS stimulation. On the whole, after LPS stimula-
tion, the relative representation of each catalog is 47% for
Disease and Disorder, 30% for Molecular and Cellular
Functions and 23% for Physiological System Develop-
ment and Function while after PMA/ionomycin stimula-
tion, the representation is 36% for Disease and Disorder,
43% for Molecular and Cellular Functions and 21% for
Physiological System Development and Function. These
results show that the predominant genes after LPS stimu-
lation are those related to Disease and Disorder while
after PMA/ionomycin stimulation, the most represented
genes are related to Molecular and Cellular Functions.
LPS-related gene networks
Thirteen LPS-related gene networks with scores over 5
were built by the IPA system (Additional file 5:
SLA_RI_Table_S5.xls). Significant gene networks specific
to LPS stimulation are presented in Figure 4. The LPS-
related network 1 was attributed the highest score (49)
and groups 28 differentially expressed genes, among
which 24 and four genes are up- and down-regulated,
respectively (Figure 4A). This network is associated with
Table 3: Top ten genes found differentially up- or down-regulated after LPS or PMA/ionomycin stimulation
LPS stimulation PMA/ionomycin stimulation
Genes Clusters2 Fold change Genes Clusters2 Fold change
Up-regulation SAA1 C4 26.84 IL2 No3 9.96
IL8 C3 23.96 HSP90AB1 C6 8.49
CCL2 C4 13.36 NPM1 C6 8.21
S100A9 C3 13.33 CD69 No3 6.87
CXCL5 C4 12.42 TNFRSF9 No3 6.62
S100A12 No3 10.92 NPM3 C6 6.61
CXCL3 No3 9.55 HSPD1 C6 6.51
CXCL2 No3 7.96 GAPDH C6 6.20
CCL8 No3 7.36 RPS2 C6 5.31
SOD2 C6 5.85 RAN C6 5.31
Down-regulation LYZ1 C1 -8.59 THBS1 C2 -65.98
FN11 C1 -7.57 FOLR11 C1 -19.74
SLA-DRB1 C8 -3.23 LYZ1 C1 -14.76
FOLR11 C1 -3.21 FN11 C1 -12.26
CST31 C8 -2.80 CSF1R C8 -8.15
SLA-DQB1 C8 -2.74 TGFBI C8 -6.78
SLA-DOB C8 -2.69 CST31 C8 -6.51
CST21 C8 -2.67 CST21 C8 -5.80
SLA-DRA C8 -2.65 CD163 No3 -5.59
SLA-DQA1 C8 -2.40 CTSZ C8 -5.58
1 Genes that are commonly down-regulated after LPS or PMA/ionomycin stimulation
2 The clusters refer to the hierarchical clustering reported in Figure 2 and Additional file 4
3 "No" means that the genes were found differentially expressed in only one stimulation condition and were not included in the hierarchical 
clustering.Gao et al. BMC Genomics 2010, 11:292
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Figure 2 Hierarchical clustering of the 316 probes found differentially expressed after LPS and PMA/ionomycin stimulations (Fisher p-val-
ue). The eight clusters C1 to C8 are partially represented. The whole clusters are provided in Additional file 4: SLA_RI_Figure_S4.png.
 Gao et al. BMC Genomics 2010, 11:292
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Table 4: LPS and PMA/ionomycin stimulation: top biological functions from the catalogs Diseases and Disorders1, 
Molecular and Cellular Functions2 and Physiological System Development and Function3 identified by IPA and number of 
focus genes
Stimulation Top biological functions # genes4 Fisher p-value
LPS Cellular Growth and Proliferation2 126/2404 2.25E-18 - 7.17E-07
Cell Death2 114/2259 2.00E-27 - 9.59E-07
Immunological Disease1 113/1730 3.40E-46 - 9.59E-07
Immune Response3 113/475 6.00E-23 - 9.56E-07
Inflammatory Disease1 108/401 2.58E-45 - 1.06E-06
Hematological System Development and Function3 101/1446 6.70E-28 - 8.53E-07
Cell-To-Cell Signaling and Interaction2 99/1465 2.44E-24 - 4.29E-07
Cellular Movement2 92/1364 6.70E-28 - 8.33E-07
Immune and Lymphatic System Development and Function3 92/430 3.43E-19 - 8.03E-07
Skeletal and Muscular Disorders1 83/2024 2.52E-39 - -2.26E-07
Cellular Development2 82/1899 1.66E-15 - 1.08E-06
Connective Tissue Disorders1 80/145 2.52E-39 - -2.26E-07
Tissue Morphology3 73/943 4.02E-20 - 8.53E-07
Tissue Development3 68/1374 6.06E-18 - 5.30E-07
Infectious Disease1 63/1087 1.60E-32 - 1.08E-06
PMA/ionomycin Cancer1 913/2395 5.41E-25 - 5.07E-08
Cellular Growth and Proliferation2 826/2404 3.15E-48 - 1.18E-08
Cell Death2 725/2259 1.10E-32 - 5.07E-08
Cellular Development2 491/1899 3.61E-32 - 4.90E-08
Hematological System Development and Function3 481/1446 1.34E-35 - 4.73E-08
Immune Response3 451/475 1.34E-35 - 4.73E-08
Immunological Disease1 433/1730 1.83E-52 - 3.92E-08
Immune and Lymphatic System Development and Function3 415/430 1.34E-35 - 2.91E-08
Inflammatory Disease1 377/401 5.57E-36 - 4.26E-09
Cell Cycle2 360/1017 4.35E-26 - 4.78E-08
Skeletal and Muscular Disorders1 327/2024 5.57E-36 - 3.41E-08
Tissue Morphology3 313/943 1.10E-32 - 2.30E-08
Connective Tissue Disorders1 294/145 5.57E-36 - 5.29E-09
Organismal Survival3 290/971 1.10E-15 - 2.41E-08
Protein Synthesis2 242/534 1.30E-29 - 6.66E-09
1 Diseases and Disorders
2 Molecular and Cellular Functions
3 Physiological System Development and Function
4 Number of genes found differentially expressed after LPS or PMA/ionomycin stimulation divided by the total number of genes represented 
on the array for the biological functions
various functions including cell death, immunological
disease and molecular transport and covers canonical
pathways, such as protein ubiquitination and antigen pre-
sentation pathways. This network represents an image of
the up-regulation of proteasome activity and peptide pro-
cessing in relationship to heat shock protein induction.
The LPS-related network 2 groups 27 differentially
expressed genes, among which 20 and seven genes are
up- and down-regulated, respectively (Figure 4B). In this
network, IL1B is in the central position together with
IL1A and CXCL3 (chemokine (C-X-C motif) ligand 3).
This network contains CD14 antigen (CD14), CD55 anti-
gen (CD55), and CD97 antigen known to be a ligand of
CD55 as well as TLR6 and TLR8. The LPS-related net-Gao et al. BMC Genomics 2010, 11:292
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work 2 is an image of the global up-regulation of the
CD14-induced cascade and cytokine signaling pathways
related to steps specific to innate immune response after
LPS stimulation in association to a down-regulation of
TLR6 and TLR8. The LPS-related network 3 consists of
25 differentially expressed genes, among which 20 and
five are up- and down-regulated, respectively (Figure 4C).
The network is associated with functions linked to immu-
nological disease, cancer, renal and urological diseases,
and concerns a series of six canonical pathways, including
purine metabolism, oxidative phosphorylation, glucocor-
ticoid receptor signaling, IL-8 signaling, hepatic fibrosis/
hepatic stellate activation and leukocyte extravasation
signaling. The MAP kinase MAP14 (alias P38MAPK), the
matrix metallopeptidases 9 and 14 (MMP9 and MMP14),
the transforming growth factor beta 1 (TGFB1) are in
central positions in this network, which groups up-regu-
lated genes involved in intracellular biochemistry modifi-
cations and in remodeling.
Complementary information on gene pathways and on
interactions between pathways was retrieved using the
Kyoto Encyclopedia of Genes and Genomes (KEGG) [19].
After LPS stimulation, 16 significant pathways with a
Fisher Exact P-Value < 0.05 were identified (Table 5, and
Additional file 6: SLA_RI_Table_S6.doc). The cytokine-
cytokine receptor interaction pathway is the most repre-
sentative pathway followed by antigen processing and
presentation and Toll-like receptor signaling pathways.
Interactions between pathways with their relative impor-
tance are presented in Figure 5A. Fourteen pathways are
interconnected and only adipocyte signaling and bladder
cancer pathways are not connected to the other path-
ways.
PMA/ionomycin-related gene networks
Ninety-eight PMA/ionomycin-related biological net-
works with a score higher than 5 were built by the IPA
system (Additional file 7: SLA_RI_Table_S7.xls). A lim-
ited number of the most interesting networks is shown on
Figure 6. In the PMA/ionomycin-related network 1 (Fig-
ure 6A), 19 and 16 genes are up- and down-regulated,
respectively. Tumor necrosis factor (TNF) is significantly
over-expressed after PMA/ionomycin stimulation and
occupies the most central position in the network. The
network is linked with numerous functions including cel-
lular development, cellular growth and proliferation,
hematological system development and function and
concerns about 30 canonical pathways representative of
the pleiotropic activities of TNF. Since most pathways
were identified by a single gene (mostly TNF), it was not
possible to connect this TNF-centered network with a
specific biological function or pathway modified by
PMA/ionomycin stimulation. Thus, we searched for net-
works with canonical pathways related to more than one
or two genes. Network 53 (Figure 6B) groups 20 down-
regulated genes, including TLR genes (TLR1, TLR6,
TLR8, TLR4), myeloid differentiation primary response
gene 88 (MYD88), interleukin-1 (IL1), receptor-associ-
ated kinases (IRAK, IRAK1 and IRAK3) and IL1 recep-
tors (IL1R and IL1R2). Network 53 also contains 14 up-
regulated genes that comprise members of the TNF-
receptor superfamily (TNFRSF18) and Ras-associated
proteins such as RAB7. The non-differentially expressed
P38MAPK gene occupies the central position and con-
nects the down-regulation of the TLR pathway to the up-
regulation of TNF receptors and vesicular transport. Net-
work 57 (Figure 6C) comprises 20 down-regulated genes
mostly associated to MHC class I presentation and inter-
feron signaling pathways, and 15 up-regulated genes
including genes involved in peptide processing before
loading onto class I molecules (ABC transporters TAP1
and 2, calnexin CANX). The most up-regulated gene i.e.
CD69 is found in this network and could be connected to
the most down-regulated gene THBS1 from network 94
and to CD47. Therefore, the network presented in Figure
6C clearly connects the strong up-regulation of a cell sur-
face glycoprotein involved in lymphocyte proliferation
and known to act as a signal-transmitting receptor in
lymphocytes, natural killer (NK) cells, and platelets [20]
and the very strong down-regulation of THBS1 that is an
adhesive glycoprotein involved in cell-to-cell and cell-to-
matrix interactions. Moreover, this network provides evi-
dence for the co-existence of an up-regulation of genes
involved in peptide processing and a down-regulation of
genes involved in antigen presentation to the cell surface.
After PMA/ionomycin stimulation, 37 KEGG pathways
with a Fisher Exact P-Value < 0.05 were identified (Table
5, and Additional file 6: SLA_RI_Table_S6.doc). The most
represented pathways are cytokine-cytokine receptor
interaction, oxidative phosphorylation, ribosome, cell
adhesion molecules (CAMs), Jak-STAT signaling path-
way, natural killer cell mediated cytotoxicity and cell
cycle. The Toll-like receptor signaling pathway occupies
the eighth position with 40 genes. Interactions between
pathways with their relative importance are presented in
Figure 5B. Globally, PMA-ionomycin stimulation mostly
modifies pathways associated with the immune system,
signaling molecules and interactions, human diseases and
metabolism like LPS stimulation but it also affects addi-
tional pathways associated to metabolism, cell growth
and death and signal transduction.
Expression of probes mapping to the SLA complex
Since sense and antisense probes for all SLA annotated
transcripts were present on the DNA chip (Table 1), it
was possible to perform an in-depth analysis of the
expression profile of all annotated transcripts mapping to
the locus. For probes targeting protein coding genes, onlyGao et al. BMC Genomics 2010, 11:292
http://www.biomedcentral.com/1471-2164/11/292
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Figure 3 Numbers of molecules in biological function categories related to the catalogs Diseases and Disorders (A), Molecular and Cellular 
Function (B) and Physiological System Development and Function (C) by IPA system.
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the differential expression was studied. For antisense and
non-coding transcripts, expression and differential
expression between stimulation and mock-stimulation
were both analyzed.
All the differentially expressed genes belonging to the
MHC antigenic processing and presentation pathway are
listed in Table 6. After LPS stimulation, all the genes asso-
ciated with the MHC class II mediated peptide presenta-
tion pathway are down-regulated. The down-regulated
genes include genes involved in peptide processing in the
late endosome (CTSB, CTSS, LGMN), peptide loading
(CD74 alias CLIP) and peptide presentation to the CD4 T
Figure 4 LPS-related gene networks identified by IPA. A: network 1, B: network 2, C: network 3. The network numbers refer to the numbers report-
ed in Additional file 5: SLA_RI_Table_S5.xls.
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Table 5: List of KEGG biological pathways associated with the genes differentially expressed after LPS or PMA/ionomycin 
stimulation
Stimulation KEGG pathway Symbol # genes1 Fisher p value
LPS Cytokine-cytokine receptor interaction CCRI 29/233 1.00E-08
Antigen processing and presentation AP_&_P 15/57 3.10E-07
Toll-like receptor signaling pathway TLR 15/89 1.88E-06
Cell adhesion molecules CAMs 13/120 6.85E-04
Hematopoietic cell lineage HCL 13/83 9.03E-06
Apoptosis Apop 11/76 1.41E-04
Type I diabetes mellitus T1D 10/31 1.88E-06
B cell receptor signaling pathway B_cell 8/67 1.60E-03
Adipocytokine signaling pathway Adip 7/58 1.25E-02
Small cell lung cancer SCLC 7/126 3.21E-02
T cell receptor signaling pathway T_cell 7/99 4.37E-02
Complement and coagulation cascades CCC 6/69 3.30E-02
Epithelial cell signaling in Helicobacter pylori infection ECs 6/59 3.10E-02
Acute myeloid leukemia AML 5/53 4.84E-02
Bladder cancer BC 5/39 1.49E-02
Alzheimer's disease AD 4/122 1.55E-02
PMA/ionomycin Cytokine-cytokine receptor interaction CCRI 74/233 4.86E-02
Oxidative phosphorylation OP 63/96 0.00E+00
Ribosome Ribosome 55/78 0.00E+00
Cell adhesion molecules CAMs 47/120 1.98E-03
Jak-STAT signaling pathway Jak-STAT 46/129 4.96E-02
Natural killer cell mediated cytotoxicity NK 44/102 9.13E-03
Cell cycle Cell_cycle 41/93 3.11E-03
Toll-like receptor signaling pathway TLR 40/89 4.14E-04
Leukocyte transendothelial migration LTEM 39/108 1.36E-02
Hematopoietic cell lineage HCL 38/83 5.22E-05
T cell receptor signaling pathway T_cell 38/99 2.16E-04
Antigen processing and presentation AP_&_P 37/57 7.05E-05
Chronic myeloid leukemia CML 30/64 1.88E-03
Pyrimidine metabolism Pyrimidine 30/68 2.07E-02
TGF-beta signaling pathway TGF-beta 30/69 2.82E-02
B cell receptor signaling pathway B_cell 28/67 3.85E-04
Adherens junction AJ 25/68 4.27E-02
Fc epsilon RI signaling pathway FeRI 25/66 4.27E-02
Adipocytokine signaling pathway Adip 24/584 4.65E-02
Renal cell carcinoma RCC 24/62 2.84E-02
Acute myeloid leukemia AML 23/53 4.47E-03
Glycolysis/Gluconeogenesis Glycolysis 23/40 1.76E-02
Pathogenic Escherichia coli infection - EHEC EHEC 21/42 8.24E-03
Pathogenic Escherichia coli infection - EPEC EPEC 21/42 8.24E-03
Proteasome Proteasome 21/43 0.00E+00Gao et al. BMC Genomics 2010, 11:292
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Type I diabetes mellitus T1D 18/31 9.62E-03
Pyruvate metabolism Pyruvate 17/31 1.32E-02
Neurodegenerative Disorders ND 16/32 1.38E-02
Aminoacyl-tRNA biosynthesis AA-tRNA 15/28 2.47E-02
Citrate cycle (TCA cycle) TCA_cycle 13/27 1.12E-02
Propanoate metabolism Propanoate 13/23 4.57E-02
Thyroid cancer TC 12/26 2.91E-02
Prion disease PD 8/34 7.98E-03
Glycosphingolipid biosynthesis - globoseries Globoseries 7/43 3.12E-02
Fatty acid elongation in mitochondria FAE 6/10 1.62E-02
Phenylalanine, tyrosine and tryptophan biosynthesis FYW 5/10 4.18E-02
Biotin metabolism Biotin 3/7 4.56E-02
1 Number of genes found differentially expressed after LPS or PMA/ionomycin stimulation divided by the total number of genes 
represented on the array for the KEGG pathways
Table 5: List of KEGG biological pathways associated with the genes differentially expressed after LPS or PMA/ionomycin 
stimulation (Continued)
cells (SLA class II genes DRA, DRBs, DQA, DQBs). After
PMA/ionomycin stimulation, a similar down-regulation
of MHC class II mediated peptide presentation pathway
is observed. In contrast, for the MHC class I mediated
peptide presentation pathway, all genes involved in pep-
tide processing and transport (PSMB5 alias LMPX,
PSMB6 alias LMPY, PSMB8 alias LMP7, PSMB9 alias
LMP2, TAP1, TAP2, CALR and CANX) are up-regulated
whereas probes targeting the classical class I genes SLA-
3, the non classical class I genes SLA-6 and SLA-7 as well
as pseudogenes SLA-4 and SLA-11 are down-regulated.
In order to analyze anti-sense oligonucleotide and non-
coding RNA probe expression, the A value (A = 1/
2(log2(Cy3*Cy5))) was used. Since the average A value of
probes corresponding to negative controls was 7.8,
probes were considered as expressed for A values higher
than 8.8 that corresponded to signal intensities twice as
high as for the controls. With such a threshold, about 30%
of the anti-sense oligonucleotide probes were found
expressed. After LPS stimulation, 135 probes corre-
sponding to anti-sense sequences derived from 93 genes
are expressed. After PMA/ionomycin stimulation, 124
probes corresponding to anti-sense sequences from 85
genes are expressed among which 121 are expressed by
PBMCs in both stimulation conditions. Anti-sense
sequences of eight genes (ABCF1, C7H6orf27, LTA,
NRM, SFTPG, snoRNAU52 (RF00276), SLA-1 and SLA-
DOB) are specifically expressed in LPS-stimulated
PBMCs. For non-coding RNA, sense probes targeting
mir-219 (RF00251) and snoRNAU84 are expressed by
PBMCs stimulated by LPS or PMA/ionomycin and the
anti-sense probe targeting snoRNAU52 (RF00276) is spe-
cifically expressed in LPS-stimulated PBMCs. Differential
analysis revealed that no non-coding RNA is differentially
expressed whatever the stimulation and that antisense
probes are regulated only after PMA/ionomycin stimula-
tion. Four probes are up-regulated (anti-sense sequences
of BAT3, IER3, EGFL8 and PSMB9) and nine probes are
down-regulated (anti-sense sequences of OLF42-3,
STK19, LSM2, AIF1, STK19, BAT1, RPP21, SKIV2L and
PPT2).
Validation of differentially expressed genes at the RNA 
level
Differential expression of 14 genes (Table 7) was validated
by quantitative real-time PCR (qRT-PCR) and the B2M
gene was included as a reference gene for data normaliza-
tion. In order to strengthen the comparison between both
technologies, qRT-PCRs were carried out using the RNA
samples that were used for microarray experiments and
the fold change was calculated for both microarray and
qRT-PCR data (Additional file 8: SLA_RI_Table_S8.doc).
For MHC mediated peptide presentation, five genes
involved in the peptide processing and presentation by
MHC class I molecules (PSMB8, PSMB9, SLAIa, TAP1
and TAP2) and three genes involved in the processing
and presentation of antigens by MHC class II molecules
(SLA-DQB, SLA-DRA and SLA-DRB1) were chosen.
Three genes CST2, LYZ and PPIA were chosen for valida-
tion because they were differentially expressed in oppo-
site directions after LPS or PMA/ionomycin stimulation.
IL1A was chosen because it was differentially expressed
only after LPS stimulation and inversely, CD69 and
TNFRSF9 were chosen because they were differentially
expressed only after PMA/ionomycin stimulation. Differ-
ential expression was confirmed for all genes and the
log2(fold change) calculated with the qRT-PCR data con-
sistently showed a greater magnitude of change com-Gao et al. BMC Genomics 2010, 11:292
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pared to the log2(fold change) calculated with the
microarray data. A highly significant correlation (R2 =
0.9021, p value < 10E-6) was calculated between the two
techniques (Figure 7).
Validation of differentially expressed genes at the protein 
level
Supernatants of mock-stimulated PBMCs and PBMCs
stimulated with LPS or PMA/ionomycin for 24 hours
were collected to measure cytokines IL-8, IL-12, TNFA
and IL-1B by enzyme-linked immunosorbent assay
(ELISA) tests. Gene expression between mock-stimula-
tion and each stimulation condition assessed by the fold
change was calculated for both microarray and ELISA
data (Table 8). Significant increased expression of IL8,
IL12, TNFA and IL1B proteins (p < 0.05) were detected
after both stimulations and confirmed up-regulation for
IL8 and IL1B at the RNA level after LPS stimulation and
up-regulation of IL8, IL12 and TNFA at the RNA level
after PMA/ionomycin stimulation. High discrepancies
were observed between RNA and protein levels for IL8,
IL12, TNF and IL1B. For LPS stimulation, RNA levels of
IL12 and TNFA were not significantly different between
mock-stimulated and stimulated cells in contrast to the
protein levels. Similarly, for PMA/ionomycin stimulation,
RNA level of IL1B was not significantly up-regulated in
contrast to the protein level. Such discrepancies could be
due to underestimation of RNA levels due to the sensitiv-
ity scale of the transcriptome analysis or to specific prop-
erties of the proteins including lability, half life time,
differences in release timing, and accumulation of the
released proteins in the supernatants.
Differential expression of MHC class I and class II mol-
ecules was validated by fluorescence-activated cell sort-
ing (FACS). FACS analysis confirmed a significant down-
regulation of MHC class I molecules at the surface of
PBMCs stimulated with PMA/ionomycin for 24 hours
compared to mock-stimulated PBMCs. The MHC class I
mean fluorescence intensity of PBMCs after PMA/iono-
mycin stimulation was 52.6% of that of mock-stimulated
PBMCs (p = 0.0096). As expected from microarray
results, no change in MHC class I molecule expression
was detected at the surface of LPS stimulated PBMCs for
24 hours. In contrast, MHC class II molecules were found
down-regulated at the surface of PBMCs in both stimula-
tion conditions compared to mock-stimulated cells. The
MHC class II mean fluorescence intensity of LPS-stimu-
lated PBMCs was 68.9% of that of mock-stimulated
PBMCs (p = 0.033) and 72.1% of that of mock-stimulated
PBMCs (p = 0.054) after PMA/ionomycin stimulation.
Discussion
The objectives of this study were first to produce a well
annotated and an easy to use DNA chip to analyze the
Figure 5 Interactions of KEGG biological pathways identified with genes found differentially expressed after LPS (A) or PMA/ionomycin 
stimulation (B). The pathway symbols are indicated in Table 5. The circle size allocated to the pathways is proportional to the number of genes in 
each pathway.
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immune response in pig and second to validate its rele-
vance by investigating transcriptome modifications in
PBMCs stimulated with LPS or PMA/ionomycin for 24
hours. The same seven biological replicates from seven
distinct animals were used for transcriptome analysis,
qRT-PCR and ELISA validation, and another set of seven
animals was used for validation by FACS analysis. Repro-
ducibility of the results was good.
Figure 6 PMA/ionomycin-related gene networks identified by IPA. A: network 1, B: network 53, C: network 57 in which THBS1 and CD47 were 
assembled by connection between CD69 and THBS1 in network 94 that was not presented here. The network numbers refer to the numbers reported 
in Additional file 7: SLA_RI_Table_S7.xls.
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Relevance of the SLA-RI/NRSP8-13K chip
DNA chips targeting immunity have been reported for
human, mouse and a few domestic species including cow
[21,22], chicken [23,24] and to a lesser extent pig with a
unique report of a nylon membrane comprising less than
100 genes [25]. Designing dedicated chips may be criti-
cized because it is contradictory to the global approach
that underlies a transcriptome study. Since no genome-
wide expression array exists for pig and since efficient
tools are required to study immunity and resistance to
disease, we have constructed a generic array enriched in
immunity genes. We combined a well-annotated oligonu-
cleotide set referred to as the NRSP8-13K set that par-
t i a l l y  c o v e r s  t h e  p i g  g e n o m e  [ 1 7 ]  t o  a  s e t  o f
oligonucleotides referred to as the SLA-RI set that targets
all annotated loci within the SLA complex and immunity
genes outside the SLA complex. Here, we report that
after LPS stimulation, among 258 differentially expressed
genes (403 probes, see Table 2), 61 were common to both
the generic and the SLA-RI sets and 84 were present only
in the SLA-RI set. Similarly, after PMA/ionomycin stimu-
lation, among 2689 differentially expressed genes, 353
were present in both sets and 424 were present only in
the SLA-RI set. The SLA-RI set was highly informative
for the analyses reported here. The SLA-RI set may be
merged with any other generic set and it is anticipated
that the number of overlapping probes between sets
should increase as a function of the genome coverage in
the next generation expression arrays. The SLA-RI/
NRSP8-13K chip was shown to be suitable to identify
immunity and disease-related biological pathways and
functions as well as to construct relevant gene networks.
Validation of differential expression was carried out for
several genes at the RNA level by qRT-PCR and at the
protein level by ELISA tests or FACS analysis. The results
show significant correlations between mRNA and protein
expression levels, confirming the accuracy of the chip
annotation. DNA chips for expression studies are cur-
rently replaced by sequence-based transcriptome using
the NGS technology, suggesting that the design of
genome-wide DNA chips could be skipped and that
sequencing could be used directly for transcriptome anal-
ysis. However, concentrating all efforts on the NGS tech-
nology might hamper the analysis of numerous animals
and samples as required for eQTL studies and genetic
genomics [26]. We are quite convinced that the NGS
technology and well-annotated DNA chips will remain
complementary for a while in domestic species. The SLA-
RI/NRSP8-13K chip reported here represents an accu-
rately annotated chip dedicated to the pig immune sys-
tem and will provide a valuable tool for diagnostics and
research.
Choice of the in vitro models to study immune response 
activation
PMA, also known as 12-O-tetradecanoylphorbol-13-ace-
tate (TPA), is a potent tumor promoter often used in bio-
medical research [27]. Ionomycin is an ionophore
produced by Streptomyces conglobatus. PMA in conjunc-
tion with ionomycin is known to activate T and B cells
and has been used in numerous immune-related studies
[25,28,29]. LPS is a major structural component of the
outer membrane of gram-negative bacteria and is a well-
referenced PAMP. LPS stimulation of mammalian cells
occurs through a series of interactions with proteins
including LPS binding protein, CD14, MD-2 and TLR4
[30]. LPS is one of the best studied immunostimulatory
components of bacteria and can induce systemic inflam-
mation and sepsis if excessive signals occur [31]. LPS-
stimulation mimics a bacterial infection and has been
extensively used to study innate immune response
[31,32]. Two recent studies in pig have reported tran-
scriptome modifications in mesenteric lymph node or
spleen after infection by Salmonella enterica serovar
Choleraesuis (S. Choleraesuis) [8] and Haemophilus para-
suis (H. parasuis) [9], respectively. S. Choleraesuis and H.
parasuis are both gram-negative bacteria. Our results on
LPS-stimulation reveal that many genes already identi-
fied after in vivo infection by S. Choleraesuis and H. para-
suis are up- or down-regulated confirming that in vitro
LPS activation of PBMCs is a good model to study innate
immune response to infection with gram negative bacte-
ria in pig.
Indeed, LPS and PMA/ionomycin stimulations were
chosen because they are widely used as gold standard in
vitro models to measure cytokines released in the
medium by PBMCs in many species. A unique time point
was studied and we are aware that all the results reported
here correspond to this unique time point i.e. 24 hours
after stimulation. It has been reported that time points
earlier than 24 hours are more relevant to decipher the
onset of the response to stimulus as shown in kinetics
studies in cow [22], pig [25], mouse [32] or human [33].
Moreover, kinetics studies have revealed that many genes
return to their basal expression level by 48 hours of stim-
ulation, suggesting that homeostasis is restored at that
time [22,25]. In this report, we were interested in study-
ing the PBMC transcriptome at the time when cytokines
released in the medium are efficiently measured. Our
results provide many candidate genes to test for kinetics
studies and ongoing complementary studies focus on this
topic.
Significant positive correlations have been reported
between transcriptomes of total PBMCs and purified
monocytes stimulated with LPS, suggesting that for stud-
ies focussing on the most differentially expressed genes,Gao et al. BMC Genomics 2010, 11:292
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Table 6: List of differentially expressed genes in MHC class I and class II presentation pathways after stimulation by LPS or 
PMA/ionomycin
Stimulation Pathway Gene symbol (Pig) Fold Change
LPS MHC I pathway HSP90AB1 1.44
HSPA5 1.41
PSMB8 1.27
PSME2 1.33
MHC II pathway CD74 -2.01
CTSB -1.38
CTSL1 2.80
CTSS -1.61
LGMN -1.81
SLA-DMA -1.82
SLA-DMB -2.12
SLA-DOB -2.69
SLA-DQA -2.40
SLA-DQB -2.34
SLA-DRA -2.50
SLA-DRB1 -2.28
SLA-DRB3 -1.68
PMA/ionomycin MHC I pathway CALR 1.84
CANX 1.64
HSP90AA1 2.06
HSP90AB1 7.72
HSP90B1 1.87
HSPA1A 1.52
HSPA1B -1.27
HSPA1L -1.33
HSPA4 1.55
HSPA5 1.84
HSPA6 3.46
HSPA8 4.16
HSPA9 2.95
HSPBP1 1.66
IFNA5 -1.48
LTA 2.18
PDIA3 1.79
PSMB5 2.68
PSMB6 2.55
PSMB8 2.10
PSMB9 2.43
PSME1 2.16
PSME2 2.56Gao et al. BMC Genomics 2010, 11:292
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separating and analysing cell subpopulations may be
unnecessary [34]. Therefore, the results reported here
correspond to the most striking transcriptome modifica-
tions during immune response activation and may miss
some subtle changes that occur in each cell subtype.
Identifying transcriptome modifications occurring in
each cell subtype is a major objective to better decipher
immune response. However, transcriptomic signatures of
blood or total PBMCs are of high interest in clinical
research and most studies relate to total PBMCs in pig
[35].
Specific transcriptome modifications after LPS stimulation
Almost half of the transcriptome modifications due to
LPS stimulation are related to Disease and Disorder bio-
logical function (see Figure 3). Most of the up-regulated
genes relate to inflammation and innate immune
response, as expected. SAA1 and pro-inflammatory
chemokines IL8, CCL2, CXCL5, CXCL3, CXCL2 and
CCL8 belong to the top-ten most up-regulated genes (see
Table 3), SAA1 being the most up-regulated gene with a
27-fold change by comparison to mock-stimulated
PBMCs. SAA1 encodes the major acute-phase protein
Serum Amyloid A (SAA), the precise role of which is still
unclear despite reports suggesting a key role in the estab-
lishment and maintenance of inflammation notably as an
antiapoptotic agent for neutrophils [36] and as an
opsonin that would facilitate phagocytosis of gram-nega-
tive bacteria [37]. SAA1 was also found as the most up-
regulated gene in spleen seven days after infection by H.
parasuis [9]. The chemokines IL8, CXCL5, CXCL3 and
CXCL2 have chemotaxis for neutrophils whereas the
chemokines CCL2 and CCL8 have a broader chemotaxis
spectrum specific for T, dendritic and NK cells as well as
monocytes and basophils [38]. Up-regulation of IL8 has
already been reported in pig PBMCs [39,40] and amnion
[41] after bacterial infection. In human, stimulation of
PBMCs with LPS induces the secretion of CCL2 [42],
CXCL3 and CXCL2 [43]. CXCL5 is up-regulated in LPS-
challenged bovine mammary epithelial cells [44]. All
these results confirm the essential role of chemokines in
chemoattraction and cell guidance to the site of infection
during bacterial infection. IL1 has been reported to acti-
vate chemokine production [45]. In our study, we found
SLA-3 -1.29
SLA-4 -1.26
SLA-6 -2.01
SLA-7 -1.29
SLA-11 -1.95
TAP1 1.85
TAP2 1.41
TNF-a 2.83
TRAP1 1.53
MHC II pathway CD74 -2.40
CTSB -2.24
CTSS -3.01
LGMN -3.71
SLA-DMA -2.06
SLA-DMB -2.31
SLA-DOA -1.38
SLA-DOB -2.50
SLA-DQA -3.14
SLA-DQB -2.62
SLA-DRA -2.83
SLA-DRB1 -3.12
SLA-DRB3 -2.05
SLA-DRB5 -1.35
Table 6: List of differentially expressed genes in MHC class I and class II presentation pathways after stimulation by LPS or 
PMA/ionomycin (Continued)Gao et al. BMC Genomics 2010, 11:292
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that IL1 was moderately up-regulated after 24 hours of
stimulation and that it occupies a central position in the
LPS-related network 2 providing a global image of
inflammation activation (Figure 4B).
We have also found other strongly up-regulated genes
after LPS stimulation including SOD2, S100A9 and
S100A12. S100A9 and S100A12 are members of the S100
family, which encodes proteins containing two EF-hand
calcium-binding motifs and are involved in the regulation
of a number of cellular processes such as cell cycle pro-
gression and differentiation. In human, S100A9 has been
reported to be up-regulated in LPS-stimulated bronchial
epithelial cells [46], suggesting that this gene has a role in
innate immune defense. SOD2 (superoxide dismutase 2)
is a member of the iron/manganese superoxide dismutase
family and it has been shown to be up-regulated in den-
dritic cells after LPS stimulation [47]. These results sug-
gest that the calcium pathways as well as oxidative
processes are strongly affected in LPS stimulated PBMCs.
Interestingly, the six genes S100A9, CXCL5, S100A12,
IL8 CXCL2 and SOD2 were also found strongly up-regu-
lated in mesenteric lymph nodes of pigs infected by S.
Choleraesuis [8] and S100A9, S100A12 and SOD2 were
also up-regulated in spleen after H. parasuis infection [9].
Overall these results confirm a predominant role of com-
mon genes in the innate immune response of pig to gram-
negative bacterial infections.
Specific transcriptome modifications after PMA/ionomycin 
stimulation
By examining the top-ten most up-regulated genes (Table
3) and the representation of KEGG pathways (see Table 5
and Figure 5B), we have found that after PMA/ionomycin
stimulation, T cells are more activated than B cells. Three
of the most up-regulated genes are IL2 (fold change close
to 10), CD69 (fold change = 6.9) and TNFRSF9 (fold
change = 6.6), which are related to T cell activation. B cell
markers such as CD40 and INHBA are also up-regulated
(Additional file 9: SLA_RI_Table_S9.xls) but with fold
changes of 1.6 and 5, respectively. It has been reported
that transcription of the cytokine IL2 is the main conse-
quence of T cell activation and that IL2 is produced by T
helper cells harboring a Th1 cytokine profile [38]. IL2 is
essential for the generation and regulation of immune
response. Binding of IL2 activates the Ras/MAPK, JAK/
Stat and PI 3-kinase/Akt signaling module pathways
(IPA, Ingenuity). IL2 signals through the IL2 receptor and
in this study, we have found that the interleukin 2 recep-
tor alpha (IL2RA) is also up-regulated after PMA/iono-
mycin stimulation as previously reported [25]. The IL-2/
IL-2R interaction stimulates the growth, differentiation
and survival of antigen-selected cytotoxic T cells [48].
The activation of T lymphocytes, both in vivo and in
vitro, induces expression of CD69 that has been reported
as the earliest inducible cell surface glycoprotein acquired
during lymphoid activation. This molecule is involved in
Table 7: Primer sequences for qRT-PCR validation
Gene name (Symbol) Forward Reverse Amplicon size (bp) Accession number
B2M1 TGGTCTTTCTACCTTCTGGTCC TGTGATGCCGGTTAGTGGTCTC 134 NM_004048
CD69 TCCTATCCCATGTGCTGTGGT GCACATATTGGCCTGGACAGT 104 NM_214091
CST2 TCTTGGAAGTGGAGATTGGCC CACAGCGTTTTCTTCTGCAGG 103 BG609449
IL1A GTGTGGTGATGGCAGCAGC GGTCGTCATCGGTGATGAACT 81 NM_214029
PSMB9 GCGCTTCACCACAAATGCTA TCCACACCAGCAGCTGTAATG 96 NM_001037961
PSMB8 TACCTGCTTGGCACCATGTCT AGTACAACCTGCACTCCTTGGC 82 NM_213935
LYZ TCTTGCGCTTCTCCTCCTTTC AAACATACCCAGTTCGCCAGG 129 NM_214392
PPIA GTCTCCTTCGAGCTGTTTGCA CCAAATCCTTTCTCCCCAGTG 83 NM_214353
SLAIa CATCATTGTTGGCCTGGTTC CCTTTTTCACCTGAGCGC 90 NM_001097431(SLA-1)
NM_001113702(SLA-2)
NM_001097427(SLA-3)
SLA-DQB AGGAGATGTCTACACCTGCCG ATTCAGACTGTGCCCGCC 80 NM_001113694
SLA-DRA ATGGGCTATCGTAGAGAATCACG CAAACATAAACTCGCCAGATTTG 80 NM_001113706
SLA-DRB1 CACAGTGGAATGGAGGGCAC AGCAGACCCAGGACGAAGC 81 NM_001113695
TAP1 CCAGTATCTCAGGGATGTTGCTG CGCTGCTTATAGCCCCACC 81 NM_001044581
TAP2 TGTTGGGTGAGACACTAATCCCTTA CAAAGGCATCAGGGTCAAAATC 81 DQ227991
TNFRSF9 TCCAGGTCACACTTCCCATGT GAACAACAGAGAAACGGAGCG 101 BE233113
1 Reference gene for qRT-PCRGao et al. BMC Genomics 2010, 11:292
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lymphocyte proliferation and functions as a signal-trans-
mitting receptor in lymphocytes, natural killer cells and
platelets [20]. TNFRSF9 also known as 4-1BB is a mem-
ber of the TNF-receptor superfamily and is a CD4+ T cell
marker that regulates CD28 co-stimulation to promote
Th1 cell response. The expression of this receptor is
induced by lymphocyte activation and is involved in T
cell division and expansion [49]. In agreement with these
findings, IL12B that is known to trigger Th1 response is
also found up-regulated with a limited fold change of 1.5.
Globally, our results show a strong up-regulation of
cytokines and genes related to Th1 response, suggesting a
more pronounced activation of the Th1 response com-
pared to a Th2 response after PMA/ionomycin stimula-
tion for 24 hours.
Strikingly, a very strong down-regulation of the THBS1
gene was observed after PMA/ionomycin stimulation for
24 hours with a reduced expression of 66 fold change by
comparison to mock-stimulation (Table 3). This gene is
also down-regulated in porcine aortic endothelial cells
treated with PMA [50] and in bovine PBMCs stimulated
with Concanavalin A [22]. Interestingly, THBS1 down-
regulation has been shown to become stronger with time
after Concanavalin A stimulation in bovine PBMCs [22],
suggesting a persistent role of this gene repression during
immune activation and a delayed response or no response
for returning to pre-induction levels. THBS1 encodes an
adhesive glycoprotein that mediates cell-to-cell and cell-
to-matrix interactions. THBS1 has been described with
many diverse functions that may relate to its structure
and consequently to its ability to bind to matrix proteins,
cell surface receptors or other molecules including cytok-
ines [51]. THBS1 is known as a potent natural inhibitor of
angiogenesis and endothelial cell migration [52]. THBS1
has been shown to be regulated by DNA methylation and
to be a target for a transcription repression induced by
the protein arginine methyltransferase 6 (PRMT6). Our
w o r k  s u g g e s t s  t h a t  t h e  s t r o n g  r e p r e s s i o n  o f  T H B S 1
observed in pig PBMCs may be due to methylation and
that the PRMT6 gene may have a role in this repression.
Interestingly, CD47, which encodes a membrane protein
that is a receptor for the C-terminal cell binding domain
of THBS1 [53] was also found slightly down-regulated
(fold change of -1.4). Recent findings suggest that THBS1
contributes to the vascular system regulation by acting
via its receptor CD47 to inhibit nitric oxide signaling [54].
Our findings suggest a major role of THBS1 repression in
T/B cell activation upon stimulation with PMA/ionomy-
cin, by enhancing the ability of cells to proliferate and
migrate. Whether this role is connected to CD47 or to
other receptors has to be further investigated.
Our study confirms an up-regulation of the pro-inflam-
matory cytokine IL8 but has not found an over-expres-
sion of IFNG as previously reported by Ledger et al. [25].
Down-regulation of MHC mediated antigen presentation 
pathways after both stimulations
A strong down-regulation of MHC class II or MHC class
I and II molecules was observed after LPS or PMA/iono-
mycin stimulation, respectively. Classical class II mole-
cules are involved in antigen presentation to CD4+ T cells
whereas classical class I genes have a double function of
Figure 7 Comparison between microarray-based and qRT-PCR-
based results by Pearson correlation scattered plots.
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Table 8: Comparison of gene expression fold change between stimulated and non stimulated PBMCs at the protein (ELISA 
tests) and RNA levels (microarray)
LPS stimulation fold change1 PMA/ionomycin stimulation fold change1
Microarray ELISA Microarray ELISA
IL8 23.95 105.79 3.12 36.73
IL12 1.03NS 7.66 1.43 7691.24
TNFA 1.23NS 7.48 2.83 1126.79
IL1B 5.00 144.81 1.04NS 136.62
1NS: not significant at p value < 0.05.Gao et al. BMC Genomics 2010, 11:292
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antigen presentation to CD8+ T cells and regulation of
natural killer cell cytotoxicity by interacting with NK
receptors such as NKG2D [55]. In pig, down-regulation
of MHC genes has been reported in vivo in the spleen of
animals infected by H. parasuis [9] and in vitro in PK15
cells infected by the pseudorabies virus [10] and in
PBMCs stimulated with PMA/ionomycin [25]. In human,
such a repression has also been reported in PBMCs
infected by bacterial LPS and diverse killed bacteria [33].
Our results show that the repression program includes
classical (DR and DQ series) and non classical (DM
series) SLA class II genes after LPS and PMA/ionomycin
stimulation as reported in human PBMCs. In addition,
classical class I genes corresponding to SLA-3 and likely
to SLA-1 and SLA-2 are also repressed together with the
non classical genes SLA-6 and SLA-7 [56] that map to the
SLA complex on chromosome 7 and CD1 that maps to
chromosome 4 thus outside of the MHC locus. Strikingly,
in our study, after PMA/ionomycin stimulation, biologi-
cal networks connect the down-regulation of MHC class
I molecules to a significant increase in transcription of
numerous heat shock proteins known to act as chaper-
ones as well as in transcription of all genes involved in the
cascade of peptide processing before loading to the MHC
molecule binding groove.
Induction of MHC class I expression is mainly tran-
scriptional and promoters of class I genes contain IFN-
stimulated response elements (ISRE) that bind factors of
the IFN regulatory factor (IRF) family. Therefore, expres-
sion of IRFs influences transcription of class I genes. In
our study, IRF1 and IRF8 are found up-regulated after
PMA/ionomycin stimulation in contrast to IRF2 and
IRF5 that are repressed. IRF8-mediated inhibition of anti-
gen presentation by dendritic cells in the tumor microen-
vironment has been described in human [57] but our
results are not in concordance with a possible role of IRF8
in MHC class I repression since the repression in peptide
presentation by class I molecules was linked with a down-
regulation of IRF8 together with a down-regulation of the
peptide processing cascade [57]. In contrast, the down-
regulation of IRF1 is in agreement with a possible role of
this gene in inhibiting transcription of MHC class I genes
[58].
Comparison of transcriptomic signatures specific to LPS 
and PMA/ionomycin stimulations
In this study, about ten times more genes are found dif-
ferentially expressed after PMA/ionomycin than after
LPS stimulation. This might be related to the fact that
LPS targets monocytes and macrophages [59] expressing
CD14 and that PMA/ionomycin have a much wider spec-
trum of target cells. However, it cannot be ruled out that
the significant difference in the number of differentially
expressed genes according to stimulation is due to varia-
tions in the dynamics of the response. The onset of
response may occur much earlier for LPS than for PMA/
ionomycin. As a counterpart, the return to basal levels of
gene transcription may also occur earlier after LPS stimu-
lation, providing a possible hypothesis for a reduced
number of differentially expressed genes after 24 hours
stimulation. Additional studies are required to specifi-
cally address this question.
Specific and common features in transcriptome modifi-
cations were identified for both stimulations at 24 hours.
Strikingly, the most significant similarly regulated genes
after both stimulations are found down-regulated and
many specific genes appear to be up-regulated.
Hierarchical clustering of genes found differentially
expressed in both stimulation conditions provided a clear
image of genes that were regulated either in the same
direction or in opposite directions according to stimula-
tion. In that respect, clusters C2, C4 and C7 (Figure 2) are
the most informative to compare signatures and target
possible markers that might be regulated in opposite
directions according to stimulation. THBS1 (cluster C2),
SAA1, chemokines CCL2, CXCL5 and CXCL6 (cluster
C4) as well as IL1 receptor, immunoglobulins and LTB
(cluster C7) provide a limited subset of genes that are spe-
cifically up-regulated after LPS stimulation and down-
regulated after PMA/ionomycin stimulation. Similarly,
cluster C7 including genes such as the chemokine
CXCL10 and IRF8 provides a reservoir of genes specifi-
cally up-regulated after PMA/ionomycin stimulation and
down-regulated after LPS stimulation.
Role of non-coding transcripts
After LPS and PMA/ionomycin stimulation, quite a high
number of probes corresponding to annotated transcripts
in the anti-sense orientation are expressed. It is likely that
the expressed antisense probes correspond to either new
non annotated transcripts or to antisense transcripts
from annotated genes. Interestingly, few of the anti-sense
probes are differentially expressed after PMA/ionomycin
stimulation suggesting a role in immune response activa-
tion that has to be further explored. These preliminary
results on the expression of non-coding transcripts map-
ping to the SLA complex corresponds to a pilot study that
would be worth extending to the whole genome.
Conclusions
We have designed a long-oligonucleotide set (SLA-RI)
comprising all the genes and pseudogenes annotated for
the SLA complex as well as immune response genes out-
side the SLA complex and produced a generic array
(SLA-RI/NRSP8-13K chip) enriched in immunity genes.
We have assessed the relevance of this DNA chip by
investigating the response of porcine PBMCs to two dis-
tinct stimuli LPS and PMA/ionomycin. Ours resultsGao et al. BMC Genomics 2010, 11:292
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reveal common as well as specific gene regulations
according to stimulation, confirming some data already
reported and providing new insights on the immune
response in pig.
Methods
Probe selection and oligonucleotide design of the SLA-RI 
oligonucleotide set
To prepare the 816 probes targeting the SLA complex, all
the annotated genes, pseudogenes and putative transcrip-
tion variants were retrieved from the VEGA database
[60]. Oligonucleotides were designed on both DNA
strands (see Additional file 1: SLA_RI_Table_S1.xls). To
select genes involved in immune response but located
outside the SLA complex, a list was drawn up from the
Porcine Immunology and Nutrition (PIN) database [61],
the human Immunogenetic Related Information Source
(IRIS) [62], the immune system pathway in KEGG [19],
and immunology microarray resources, such as ARK-
Genomics S. scrofa Immune Array 3 K v1.0 [14], the
Affymetrix GeneChip® Human Immune and Inflamma-
tion 9 K SNP Kit, Oligo GEArray® Human Autoimmune
and Inflammatory Response Microarray, Oligo GEArray®
Human Hematology/Immunology Microarray, Oligo
GEArray®  Human Innate and Adaptive Immune
Responses Microarray, Oligo GEArray® Human Inflam-
matory Cytokines & Receptors Microarray, the PIQOR™
Immunology Microarray for human, and the PIQOR™
Immunology Microarray for mouse. Pig sequences were
retrieved by GeneID and RefSeq search or by analysis for
s e q u e n c e  s i m i l a r i t y  b y  B L A S T  ( s e e  A d d i t i o n a l  f i l e  1 :
SLA_RI_Table_S1.xls). In cases where no pig sequence
could be identified, a human sequence was used for the
oligonucleotide design. Thus, the gene list comprises
2832 pig sequences and 125 human sequences and the
final set consists of 2957 oligonucleotides. GO annota-
tions of the probes were retrieved using the correspond-
ing human RefSeq IDs [63,64]. Oligonucleotides were all
designed and synthesized by Operon Company.
Design and production of the SLA-RI/NRSP8-13K chip
The SLA-RI/NRSP8-13K chip was designed by combin-
ing the SLA-RI set with the NRSP8-13K set, which was
purchased from the Operon Company. Oligonucleotides
were resuspended in 0.5× Pronto! Universal Spotting
Solution (Corning, USA) at a final concentration of 20
pmol/μL and printed on Corning UltraGAPS slides using
a Chipwriter (Virtek, Canada) with 48 microspotting pins
(SMP3, TeleChem International, Inc. USA). The Lucidea
Universal ScoreCard control samples (GE Healthcare,
USA) and SpotReport® Alien® cDNA Array Validation Sys-
tem control samples (Stratagene, USA) were both spotted
in four replicates. After spotting, slides were air-dried and
DNA was UV-fixed (600 mJ). Slides were stored in dry
atmosphere before use. All information on SLA-RI/
NRSP8-13 microarray platform has been submitted to
the Gene Expression Omnibus (GEO) repository and the
accession number is GPL7151. The DNA chips were pro-
duced by the French National platform CRB GADIE [65]
and can be purchased upon request.
Cell isolation and stimulation
PBMCs from seven Large White male pigs (~50 kg) were
isolated by Ficoll-Hypaque density gradient centrifuga-
tion at room temperature. The PBMCs were cultured in
RPMI 1640 medium (BioWhittaker, Belgium) supple-
mented with 10% heat-inactivated FBS (fetal bovine
serum) (QB perbio, UK), 2 mmol/L L-glutamine, 100 U/
mL penicillin and 100 mg/mL streptomycin. In our
experimental conditions, 5 × 106 cells were incubated for
24 hours in culture medium supplemented with 1 μg/mL
LPS from E. coli O111:B4 (Sigma, France) or a mixture of
PMA (Sigma, France) at 10 ng/mL and ionomycin
(Sigma, France) at 1 μg/mL. For mock-stimulation, cells
were maintained in the culture medium for 24 hours.
PBMCs were further centrifuged for 10 min at 4000 rpm
and harvested for RNA extraction. Supernatants were
f r o z e n  a t  - 2 0 ° C  f o r  c y t o k i n e  q u a n t i f i c a t i o n  b y  E L I S A
tests.
RNA isolation and quality control
Total RNA was extracted from cells using the RNeasy
Midi Kit (Qiagen, USA) and purified by on-column diges-
tion of DNA with DNase I as recommended by the manu-
facturer (Qiagen, USA) to eliminate residual genomic
DNA. RNA concentration was determined by Nanodrop
quantification (Thermo Fisher Scientific Inc., USA). RNA
quality was checked on an Agilent 2100 Bioanalyzer (Agi-
lent Technologies, Germany). RNAs with a RIN score
between 8 and 10 were labeled and used for microarray
and qRT-PCR experiments. All RNAs were diluted to a
final concentration of 1 μg/μL and stored at -80°C.
RNA labelling, microarray hybridisation and signal 
quantification
For labelling, 5 μg of total RNA were reverse-transcribed
and directly labelled by Cy3 or Cy5 using the ChipShot™
Direct Labeling System (Promega, USA). The CyDye-
labelled cDNAs were purified using ChipShot™ Mem-
brane Clean-Up System (Promega, USA). The absorbance
at 260, 550 and 650 nm of CyDye-labelled cDNAs was
measured by Nanodrop (Thermo F isher Scientific Inc.,
USA). Frequency of incorporation (FOI) and labelling
e f fi c i e n cy  w e r e  c h ec k ed  b y  r e f e rri n g  t o  s ta n da r ds  p r o -
vided by Labeled cDNA Calculator [66] (Promega, USA).
The CyDye-labelled cDNAs were dried by vacuum cen-
trifugation and resuspended at a final concentration of
2.5 pmol/μL in cDNA/long-oligonucleotide hybridizationGao et al. BMC Genomics 2010, 11:292
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buffer. A dye swap hybridization scheme was designed to
compare gene expression between mock-stimulated
PBMCs and PBMCs stimulated by either LPS or a mix-
ture of PMA and ionomycin. Each pig/condition RNA
was labelled with Cy3 and Cy5 (Additional file 10:
SLA_RI_Figure_S10.png). A total of 28 SLA-RI/NRSP8-
13K chips were used in our study. Chip hybridization was
performed using the Corning hybridization system. Prior
to hybridization, the slides were treated with the back-
ground-reducing Pronto! Pre-Soak System (Corning,
France) and then prehybridized using the Corning
"Pronto! Universal Hybridization Solutions and Kits"
(Product #40026). Hybridizations were carried out for 16
hours at 42°C in light-protected sealed Corning Hybrid-
ization Cassettes (Corning, Product #2551) placed in a
water bath. The slides were washed according to the rec-
ommended protocol (Corning, Product #40026) and
dried by centrifugation at 1600 rpm for 2 min. Slides were
scanned using a GenePix™ 4000B array scanner (MDS
Inc., Canada) and then array images were processed with
the GenePix™ Pro software V6.0 (MDS Inc., Canada) to
align spots, to integrate ID data files and to export reports
of spot intensity data.
All the results were stored in the BioArray Software
Environment (BASE) managed by SIGENAE [67]. The
microarray data have been submitted to the GEO and
received the accession number GSE17320.
Microarray data statistical analysis
To identify any significant differential expression, the
microarray data were analyzed using Limma (Linear
Models for Microarray Data) [68] from the Bioconductor
open-source project running under R [69,70]. After data
pre-processing using within-array global loess normaliza-
tion, the empirical eBayes method in Limma, which com-
putes moderated t-statistics, moderated F-statistics, and
log-odds of differential expression, was applied to identify
the significance of differential expression in each culture
condition. Adjustment for multiple testing was carried
out using the false discovery rate (FDR) method [71] in
Limma. Significant changes in gene expression were lim-
ited to p < 0.05. Hierarchical clustering analysis (HCL)
was performed for gene classification [72] using the
TMeV software [73].
Significant functions and gene network analysis
The differentially expressed genes were analyzed using
the IPA software (Ingenuity Systems, USA). Genes with
known human locus IDs with corresponding differential
expression values were uploaded into the software. Each
human locus ID was mapped to its corresponding gene
object in the Ingenuity Pathways Knowledge Base. Gene
networks were algorithmically generated based on their
connectivity and assigned a score. Ingenuity Pathways
Analysis calculates a significance score for each network.
The score is calculated using a p-value calculation for
each network, and is displayed as the negative base-ten
logarithm of that p-value. It indicates the likelihood that
the assembly of a set of focus genes in a network may be
explained by random chance alone. In this study, the cut-
off significant score was set at 5, which means that a net-
work score of 5 would only have approximately a 10-5
chance of occurring randomly. The KEGG biology path-
way information for differentially expressed genes was
queried by ArrayTrack [74,75] using human locus IDs.
The interconnectedness information was manually
extracted from the KEGG pathways, and for simplicity a
line connecting two KEGG pathways was used to repre-
sent these interactions. The interaction map was created
using CytoScape software [76] to generate a framework of
the interactions of the KEGG biological pathways.
Quantitative real time RT-PCR (qRT-PCR)
Two μg of DNaseI-treated total RNAs were reverse-tran-
scribed using Superscript II enzyme with Oligo(dT)
primers. The cDNAs were quantified using a 2100 Bioan-
alyzer (Agilent Technologies, Germany) and diluted to a
working concentration of 4 ng/μL. Duplicate reactions
were performed in a final volume of 20 μL with 20 ng
cDNA, 300 nM primers and SYBR Green PCR Master
Mix (Applied Biosystem, USA), using an ABI PRISM
7900 HT sequence detection system (Applied Biosystem,
USA). Primers were chosen either with the Primer
Express Software or manually. The gene B2M was chosen
as the internal reference gene and the 2-ΔΔCt method was
used to calculate the fold change in gene expression [77].
ELISA test validation
For protein validation by ELISA tests, supernatants of
mock-stimulated and stimulated PBMCs from the seven
animals used for transcriptome analysis were tested. This
means that supernatants for ELISA tests and PBMCs for
RNA extraction and transcriptome analysis were col-
lected at the same time from the same culture plates. The
concentrations of IL8, IL12, IL1B and TNFA proteins
were determined using commercially available ELISA kits
(DuoSet, R&D Systems, USA), according to the manufac-
turer's instructions. Results were reported as the mean
values of duplicate ELISA wells.
FACS analysis
The anti-porcine MHC Class I monoclonal antibody
PT85A (VMRD Inc., USA) and the anti-porcine MHC
Class II monoclonal antibody MSA3 (VMRD Inc., USA)
were used for FACS analysis. The monoclonal antibody
HOPC-1 (IgG2a, Beckman Coulter, USA) was used as a
control antibody for isotype. PE-conjugated goat antibod-Gao et al. BMC Genomics 2010, 11:292
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ies to mouse IgG2a (Southern Biotech, USA) were used as
a secondary antibody.
PBMCs from seven other Large White male pigs were
stimulated and mock-stimulated in the same conditions
as for microarray analysis. After centrifugation at 1500
rpm for 20 min at 4°C, cells were resuspended and incu-
bated in pig serum for 25 min at 4°C. Cells were washed
in PBS (BioWhittaker, Belgium) and incubated with 50 μL
of diluted primary antibody (1/200 in FACS buffer) for 25
min at 4°C, then washed again and incubated with 50 μL
of diluted PE-conjugated goat antimouse IgG2a (1/600 in
FACS buffer) for 25 min at 4°C in light-protected cham-
bers. After a final wash in PBS, PBMCs were fixed in BD
CellFix (BD Biosciences, USA) solution and analyzed
using a FACS Calibur flow cytometer (BD Biosciences,
USA).
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with a reversed labeling of cDNAs by Cy3 or Cy5. Arrow heads represent 
Cy5 and arrows point in the Cy3 to Cy5 direction.
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